Repositioning of a cyclin-dependent kinase inhibitor GW8510 as a ribonucleotide reductase M2 inhibitor to treat human colorectal cancer

Overview of attention for article published in Cell Death Discovery, May 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

blogs: 1 blog
twitter: 1 X user

patent: 1 patent

Citations

dimensions_citation: 40 Dimensions

Readers on

mendeley: 51 Mendeley

Summary Blogs X Patents Dimensions citations

So far, Altmetric has seen 1 blog post.

CDK Inhibitors: Purchase With Caution

In the Pipeline, 10 Oct 2018

Cyclin-dependent kinase (CDKs) have been drug targets for quite a while now. There are 20 different ones, and they help to…